So with Davie at the top of this franchise, how well is this going to go? http://www.bloomberg.com/news/articles/2015-03-20/astrazeneca-lags-in-cancer-race-where-losing-may-invite-takeover
AZ is for sale to the next highest bidder. The bluff with Pfizer didn't work and now we will be lucky if the next sucker offers $75 a share.